Dies ist eine HTML Version eines Anhanges der Informationsfreiheitsanfrage 'The Vaccines Procurement Steering Committee & the Joint Negotiation Team'.



contract process. It was outlined that Valneva proposed a different technology and 
Members agreed it would be useful to have it in the portfolio. 
 
 - as discussions with the company were concluded, the Steering Board should 
decide on launching the contract process. 
 
 a number of exploratory discussions were carried so far. 
 
4.  Vaccination strategies 
Given the various (centralised/decentralised) strategies in the Member States, the 
Members enquired about the best framework for a discussion in the SB. 
The Commission and the Members agreed on the importance of unity amongst the 
Member States regarding the implementation of the vaccines strategies.  
The importance of waiting for the formal evaluation and the (conditional) marketing 
authorisation  
was also underlined. Such authorisation provides for a controlled and 
robust framework for assessment and is different from Emergency Use Authorisations, 
which will be used by other countries. 
 
 
The Members expressed the wish to have a platform where to share the national 
vaccination strategies
, which are also discussed in the HSC. 
 informed about the creation of an informal Group on Vaccination Strategy and 
Logistics and invited MSs to attend and to extend the invitation to the experts on 
vaccination strategy and/ or logistics. 
 
5.  COVAX 
The Commission provided an update on the state of play on the COVAX APAs and 
informed that 
 doses were negotiated (via MoUs), as follows:  

,  



 with the 
 (
 and 
 

presented at length the concept paper on donations, outlining: 
(i) 
the  objectives- securing access to the vaccine for the top priority group and the 
most vulnerable around the world;